Search Within

Michael Forman Berger

  1. "Jinru Shia"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (32)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (65)
  2. Department of Pathology and Laboratory Medicine (65)
  3. GSK Faculty (65)
  4. Human Oncology and Pathogenesis Program (65)
  5. Department of Medicine (58)
  6. Solid Tumor Oncology Division (58)

More Groups

People
  1. Jinru Shia (65)
  2. David Solit (43)
  3. Jaclyn Hechtman (32)
  4. Zsofia Stadler (32)
  5. Rona Yaeger (26)
  6. Nikolaus Schultz (25)

More People

Years
  1. 2025 (4)
  2. 2024 (1)
  3. 2023 (9)
  4. 2022 (2)
  5. 2021 (5)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Modern Pathology (8)
  3. Laboratory Investigation (6)
  4. JCO Precision Oncology (4)
  5. Cancer (3)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (23)
  2. Nature Publishing Group (12)
  3. American Association for Cancer Research (8)
  4. Nature Research (8)
  5. Oxford University Press (4)
  6. Wiley Blackwell (3)

More Publishers

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical utility and prognostic implications of circulating cell-free DNA in biliary tract cancer
    Journal Article

    Cowzer, D.; Darmofal, M.; Seier, K.; Thummalapalli, R.; Walch, H.; El Dika, I.; Khalil, D. N.; Park, W.; Dhyani, A.; Yaqubie, A.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencing
    Journal Article

    Ziegler, J.; Hechtman, J. F.; Rana, S.; Ptashkin, R. N.; Jayakumaran, G.; Middha, S.; Chavan, S. S.; Vanderbilt, C.; DeLair, D.; Casanova, J.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy
    Journal Article

    Cowzer, D.; Chou, J. F.; Walch, H.; Keane, F.; Khalil, D.; Shia, J.; Do, R. K. G.; Yarmohammadi, H.; Erinjeri, J. P.; El Dika, I.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Prevalence and clinical implications of mismatch repair-proficient colorectal cancer in patients with Lynch syndrome
    Journal Article

    Ranganathan, M.; Sacca, R. E.; Trottier, M.; Maio, A.; Kemel, Y.; Salo-Mullen, E.; Catchings, A.; Kane, S.; Wang, C.; Ravichandran, V.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Targeted molecular profiling of circulating cell-free DNA in patients with advanced hepatocellular carcinoma
    Journal Article

    Cowzer, D.; White, J. B.; Chou, J. F.; Chen, P. J.; Kim, T. H.; Khalil, D. N.; El Dika, I. H.; Columna, K.; Yaqubie, A.; Light, J. S.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade
    Journal Article

    Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)
    Meeting Abstract

    Cowzer, D.; Capanu, M.; Keane, F.; Khalil, D.; Shia, J.; Do, R.; Chou, J.; Walch, H.; El Dika, I.; Yaqubie, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save